Mark Chin

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
London, United Kingdom
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
By: /s/ Rahul Khara, as Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Mark Chin

Form 4 holding Director

IMARA Inc.

Security class
Common Stock
Shares / value
2,344,072
Estimated value
$35,477,530
Report date
02 Jun 2022
Price
$15.14
Ownership
By entities affiliated with Arix Bioscience plc
Form 4 holding Director

Iterum Therapeutics plc

Security class
Ordinary Shares
Shares / value
18,306
Estimated value
$25,628
Report date
15 Jun 2023
Price
$1.40
Ownership
Direct
Form 4 holding Director

IMARA Inc.

Security class
Stock Options (Right to Buy)
Shares / value
8,500
Estimated value
Report date
02 Jun 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Disc Medicine, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
6,212
Estimated value
Report date
18 Jun 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Harpoon Therapeutics, Inc.

Security class
Director Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
11 Mar 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Iterum Therapeutics plc

Security class
Restricted Share Units
Shares / value
0
Estimated value
Report date
15 Jun 2023
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
Form 4 holding Former Director

Pyxis Oncology, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
Report date
21 Apr 2022
Price
$1.40
Ownership
Indirect

Insider Reports Filed by Mark Chin

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .